Skip to content

Annexon ANNX Price / book

Price / book at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
2.6×+0.2×
Dianthus Therapeutics logo
Dianthus TherapeuticsDNTH
3.7×+1.9×
Omeros logo
OmerosOMER
16.7×
Vor Biopharma logo
Vor BiopharmaVOR
1.4×0.0×
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
1.5×+0.3×
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
3.6×-5.6×

Other financials

Income statement

See full
Operating income-$46.1M+19.8%
Net income-$44.1M+18.8%
EPS (diluted)-$0.23+37.8%

Balance sheet

See full
Cash & equivalents$175.2M+80.4%
Total debt$25.4M-10.2%
Total equity$204.5M-16.1%
Total assets$262.9M-13.2%

Cash flow

See full
Operating cash flow-$46.8M+6.5%
CapEx--100%
Free cash flow-$46.8M+6.6%

Valuation

See full
Market cap$843.79M+223%
Enterprise value$694.02M+261%

Returns & leverage

See full
Return on equity-87.6%+42.3pp
Debt / equity0.1×0.0×
Current ratio6.4×-1.6×

Where this comes from

Calculated from Annexon’s reported figures.

Based on the most recent quarter.

The official record: Annexon’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Annexon's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Annexon's price / book?
Annexon (ANNX) reported price / book of 4× in Q1 2026.
How has Annexon's price / book changed year-over-year?
Annexon's price / book increased by 364.9% year-over-year, from 0.9× to 4×.
What is the long-term trend for Annexon's price / book?
Over 5 years (2020 to 2025), Annexon's price / book has grown at a 4.8% compound annual growth rate (CAGR), from 2.8× to 3.5×.
What does price / book mean?
Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.